BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26758495)

  • 1. Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines.
    Kumura K; Wakiyama Y; Ueda K; Umemura E; Watanabe T; Shitara E; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2016 Jun; 69(6):440-5. PubMed ID: 26758495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of novel lincomycin derivatives. II. Exploring (7S)-7-(5-aryl-1,3,4-thiadiazol-2-yl-thio)-7-deoxylincomycin derivatives.
    Kumura K; Wakiyama Y; Ueda K; Umemura E; Watanabe T; Kumura M; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2017 May; 70(5):655-663. PubMed ID: 27924113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 4: synthesis of novel lincomycin analogs modified at the 6- and 7-positions and their potent antibacterial activities.
    Wakiyama Y; Kumura K; Umemura E; Ueda K; Watanabe T; Yamada K; Okutomi T; Ajito K
    J Antibiot (Tokyo); 2017 Jul; 70(8):888-906. PubMed ID: 28559581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities.
    Umemura E; Wakiyama Y; Kumura K; Ueda K; Masaki S; Watanabe T; Yamamoto M; Hirai Y; Fushimi H; Yoshida T; Ajito K
    J Antibiot (Tokyo); 2013 Mar; 66(3):195-8. PubMed ID: 23232934
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of novel lincomycin derivatives. IV. Optimization of an N-6 substituent.
    Kumura K; Wakiyama Y; Ueda K; Umemura E; Hirai Y; Yamada K; Ajito K
    J Antibiot (Tokyo); 2017 Dec; 70(12):1112-1121. PubMed ID: 29115289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions.
    Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Sato Y; Hirai Y; Hayashi Y; Ajito K
    J Antibiot (Tokyo); 2018 Feb; 71(2):298-317. PubMed ID: 29089594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs.
    Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Sato Y; Watanabe T; Hirai Y; Ajito K
    J Antibiot (Tokyo); 2017 Jan; 70(1):52-64. PubMed ID: 27703159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
    Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Watanabe T; Yamamoto M; Hirai Y; Ajito K
    J Antibiot (Tokyo); 2016 Jun; 69(6):428-39. PubMed ID: 26669751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
    Ma C; Liu Z; Song H; Jiang R; He F; Ma S
    J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 1. Newly generated antibacterial activities against Gram-positive bacteria with erm gene by C-7 modification.
    Wakiyama Y; Kumura K; Umemura E; Ueda K; Masaki S; Kumura M; Fushimi H; Ajito K
    J Antibiot (Tokyo); 2016 May; 69(5):368-80. PubMed ID: 26669755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial evaluation of novel 11-O-aralkylcarbamoyl-3-O-descladinosylclarithromycin derivatives.
    Jia L; Wang Y; Wang Y; Qin Y; Hu C; Sheng J; Ma S
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2471-2476. PubMed ID: 29880401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
    Ma S; Jiao B; Ju Y; Zheng M; Ma R; Liu L; Zhang L; Shen X; Ma C; Meng Y; Wang H; Qi Y; Ma X; Cui W
    Eur J Med Chem; 2011 Feb; 46(2):556-66. PubMed ID: 21159410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of novel 4''-O-carbamoyl erythromycin-A derivatives.
    Qi Y; Jiao B; Ma X; Cui W; Ma S
    Arch Pharm (Weinheim); 2010 Aug; 343(8):458-64. PubMed ID: 20803622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimicrobial activity of 1-(p-substituted)phenyl-3-(p-alkoxy)phenyl-4-phenyl-azetidin-2-ones.
    Diurno MV; Cristinziano A; Mazzoni O; Piscopo E; Bolognese A
    Farmaco; 1995 Feb; 50(2):143-8. PubMed ID: 7766278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of novel 4''-O-arylalkylcarbamoyl and 4''-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives.
    Ju Y; Xian R; Zhang L; Ma R; Cao J; Ma S
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3272-4. PubMed ID: 20462756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
    Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
    Huang X; Bao Y; Zhu S; Zhang X; Lan S; Wang T
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3928-32. PubMed ID: 26238324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological screening and molecular modeling studies of novel 3-chloro-4-substituted-1-(2-(1H-benzimidazol-2-yl)phenyl))-azetidin-2-ones.
    Chhajed SS; Upasani CD
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):504-8. PubMed ID: 21823835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
    Balsamo A; Barontini S; Calvani F; Gentili D; Macchia M; Rossello A; Di Modugno E; Felici A
    Bioorg Med Chem Lett; 1999 Apr; 9(7):1035-40. PubMed ID: 10230635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides.
    Jia L; Yan M; Shen Y; Qin Y; Qiang S; Ma S
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3693-3697. PubMed ID: 28711353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.